orphenadrine citrate
Drug Details
- Generic Name
- orphenadrine citrate
- Brand Names
- Orphenadrine Citrate
- Application Number
- ANDA090585
- Sponsor
- Sagent Pharmaceuticals
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS
- Active Ingredients
- ORPHENADRINE CITRATE
Indications and Usage
INDICATIONS AND USAGE Orphenadrine citrate extended-release tablets are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.
Warnings
WARNINGS Some patients may experience transient episodes of light-headedness, dizziness or syncope. Orphenadrine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.